Analyst action: Acadia, Brookdale

Analysts at Cantor Fitzgerald have begun covering shares of Acadia Healthcare with a 'buy' rating and a $35 price target that implies another 25 percent of upside from where the company (Ticker: ACHC) opened trading Tuesday. By Thomson/First Call's reckoning, the target is now the highest on the Street for Acadia. (Separately, Acadia execs said Tuesday they've wrapped up a $150 million debt raise and paid down $52 million in high-interest 2018 notes.)

In contrast, the sentiment is nowhere near as upbeat at Macquarie when it comes to Brookdale Senior Living. The firm's analysts launched coverage of the skilled-nursing provider with a 'neutral' rating in December but have already lowered their opinion to 'underperform.' We couldn't dig up any details as to whether it's a pure valuation call — the stock (Ticker: BKD) is up 15 percent year to date — or if there's more to the move.